SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The company announced the immediate departure of two senior executives: Greg Dale (Chief Operating Officer) and Frank Friedman (Head of Measurement and Chief Data and Analytics Officer). Their responsibilities are being assumed by the CEO.
View raw filing on EDGAR →Brian C. Thomas, Ph.D. resigned from his position as a member of the Board of Directors effective June 9, 2026, with the Company confirming the resignation was not due to disagreement.
View raw filing on EDGAR →Mr. Matan Fattal resigned as a director and member of multiple committees effective June 5, 2026. While the resignation itself was not disputed, the departure triggered material consequences: the Company lost compliance with Nasdaq Listing Rule 5605(c)(2)(A) (minimum three-member audit committee) and 5605(b) (majority independent board requirement), creating delisting risk that a reasonable investor would find material to their investment decision.
View raw filing on EDGAR →Jay Kim resigned as Co-Chief Executive Officer on June 4, 2026. Jung Jae Lim assumed full CEO responsibilities following Kim's departure.
View raw filing on EDGAR →Martijn Dekker resigned as a director effective June 3, 2026. This is a clear departure of a director from the company, which is material to investors as it affects board composition and governance. The filing discloses the resignation date and the director's name explicitly.
View raw filing on EDGAR →Dzmitry Kastahorau, the Chief Financial Officer, resigned effective immediately on June 3, 2026. The departure of a principal financial officer is a material executive change that would affect a reasonable investor's assessment of the company's leadership and financial oversight. The filing explicitly states the resignation was not due to disagreement, but the departure itself remains material.
View raw filing on EDGAR →William Dabbs Cavin resigned as a director of Open Lending Corporation effective immediately on June 8, 2026. This is a clear departure event — a director leaving the board. While the filing notes the resignation was not due to any dispute, the departure of a board member is material to investors as it affects the composition and governance of the company.
View raw filing on EDGAR →All of Legato's directors and officers resigned effective upon consummation of the business combination, representing a complete change in governance and control of the company.
View raw filing on EDGAR →Bradford T. Nordholm, President and Chief Executive Officer of Federal Agricultural Mortgage Corporation, retired effective July 1, 2026, following mutual agreement with the Board on June 3, 2026.
View raw filing on EDGAR →William Reinhardt's retirement from the Board of Metropolitan Bank Holding Corp. and its subsidiary Metropolitan Commercial Bank, effective immediately on June 6, 2026, constitutes a departure of a director. While the disclosure also mentions his honorary designation as director emeritus, the principal disclosed action is his departure from the board, which is material to investors assessing the composition and governance of the registrant.
View raw filing on EDGAR →Jeremy Chadwick, Chief Operating Officer, resigned effective June 5, 2026, for personal reasons. The disclosure centers on the departure of a named executive officer from a C-suite position, which is material to investors assessing management continuity and operational leadership. While he remains as an advisor through November 2026, the principal event is his resignation from the COO role.
View raw filing on EDGAR →Jesse A. Coury's resignation as Chief Financial Officer effective June 30, 2026, is the principal disclosed action. While the filing also announces Eric R. Nielsen's appointment as interim CFO, the core event centers on the departure of the CFO. The filing explicitly states the resignation is unrelated to any disagreement, and Nielsen's appointment is characterized as interim pending a permanent replacement, making the departure the more salient event.
View raw filing on EDGAR →The Board of Directors approved the termination of Craig Huffman from his position as Chief Legal Officer effective immediately. This is a clear executive departure—the principal disclosed action is a named officer leaving his role. The termination of a C-suite legal officer is material to investors as it affects the company's governance and compliance leadership structure.
View raw filing on EDGAR →Rick Dunn, the Chief Financial Officer, is stepping down from his position at the conclusion of a transition period following a mutual agreement with the Company. While the disclosure also includes severance terms (base salary continuation, COBRA, and RSU acceleration), the principal disclosed action is the departure of a named executive officer. The CFO role is material to investor assessment of the company's financial management and governance.
View raw filing on EDGAR →The filing discloses the separation of Mannix Aklian, Chief Commercial Officer and Global Head of Software Sales and Marketing, formalized through a transition and separation agreement dated June 5, 2026. While the disclosure includes detailed severance and compensation terms, the principal disclosed action is Aklian's departure from the Company. The separation of a C-suite executive responsible for commercial operations and sales is material to investors' assessment of the registrant's leadership and business continuity.
View raw filing on EDGAR →Hongyu Zhou, Chairman of the Board of AiRWA Inc., resigned from the Board effective immediately on June 2, 2026. This is a clear executive departure of a senior officer (board chair). The filing explicitly states the resignation was not due to disagreement with the company, but the departure of a chairman is material to investors' assessment of corporate governance and leadership continuity.
View raw filing on EDGAR →Three directors—Eric S. Rosenfeld, David D. Sgro, and Anthony Laura—were removed from the Board of Directors on June 7, 2026, pursuant to the Company's Bye-Laws provision 24.1.7. The removal of three board members simultaneously represents a material change in the composition of the Company's governance structure and would affect a reasonable investor's assessment of the registrant's leadership and strategic direction.
View raw filing on EDGAR →Maroun S. Mourad, President of Intellectual Property, departed his executive position effective June 9, 2026, though remaining in a non-executive advisory role through September 30, 2026, with severance terms including cash bonus, COBRA reimbursement, and potential tax equalization.
View raw filing on EDGAR →Ankur Sinha, Chief Product and Technology Officer, provided notice of resignation effective June 19, 2026. This is a clear departure of a named executive officer from a senior role responsible for product and technology strategy. The filing explicitly states the resignation did not result from disagreement on financial reporting, which is a standard disclosure but does not diminish the materiality of losing a C-suite executive.
View raw filing on EDGAR →Jason D. Lippert, Chief Executive Officer, retired and resigned from the Board effective June 3, 2026. The departure included a separation agreement with consulting services and equity vesting provisions through June 2027.
View raw filing on EDGAR →Donald J. LaBauve Jr., the Chief Accounting Officer, retired on June 1, 2026. While the filing also discloses that Neal R. Sheorey will serve as interim Principal Accounting Officer, the principal disclosed action is the departure of the former CAO. The retirement of a Chief Accounting Officer is material to investors as it affects the registrant's financial reporting oversight and internal controls.
View raw filing on EDGAR →Carrie D'Andrea, Vice President of Clinical Operations, is ceasing employment effective June 5, 2026. While the disclosure also mentions severance benefits and a consulting agreement, the principal disclosed action is the departure of a named officer. The filing centers on her separation from the Company, making exec_departure the most salient classification, though the compensation elements (severance and consulting fee) are secondary to the departure itself.
View raw filing on EDGAR →David Bailey, a co-founder and board member of RTB Digital, is departing the board of directors effective June 1, 2026, to focus on his CEO role at Nakamoto, Inc. The filing explicitly states his departure and notes he was a "founding investor and board member" who participated in recent funding rounds. While the departure is amicable and not due to disagreement, the loss of a founding board member who was actively involved in capital raises is material to investors' assessment of the company's governance and continuity.
View raw filing on EDGAR →Reid Hoffman, a Board member since 2017, informed Microsoft on June 2, 2026 that he will not stand for re-election at the 2026 annual shareholder meeting. Although he will remain in office until the Annual Meeting, the principal disclosed action is his departure from the Board. Board-level departures at major public companies are material to investors assessing governance and continuity.
View raw filing on EDGAR →Mark A. Alexander's resignation from the Board of Directors of Builders FirstSource, Inc., effective immediately on June 3, 2026, constitutes a director departure. The filing explicitly states the resignation was due to health reasons and clarifies there was no disagreement with the Company. Director changes are material events affecting the composition and governance of the registrant.
View raw filing on EDGAR →Terence J. Voskuil, Executive Vice President and Chief Technology Officer, Aerospace, notified the company on June 2, 2026 of his intention to retire effective October 2, 2026. This is a clear executive departure of a named officer at the C-suite level, and the departure of a CTO in a technology-dependent aerospace company would materially affect investor assessment of the registrant's leadership and technical direction.
View raw filing on EDGAR →Andrew Rolfe retired from the Board of Directors, resulting in a reduction in board size. This departure is material to investors assessing governance structure and board effectiveness.
View raw filing on EDGAR →Thomas C. Chubb, III resigned from the Board of Flowers Foods, Inc. effective immediately on June 4, 2026, citing competing professional demands as chairman, president and CEO of Oxford Industries. The disclosure emphasizes his six years of service and leadership roles including independent presiding director and chair of the Nominating/Corporate Governance Committee, making this a material departure of a senior director.
View raw filing on EDGAR →Mr. Jordan Krugman's resignation from all positions at Invesco Capital Management LLC and its affiliates, including his position as a member of the Board of Managers of the Sponsor, effective August 3, 2026, constitutes a departure of an officer/manager. The disclosure is made under Item 5.02(b) and explicitly states the resignation notice and effective date, which are hallmarks of an executive departure event.
View raw filing on EDGAR →Mr. Jordan Krugman resigned from all positions at Invesco Capital Management LLC, the Managing Owner of the fund, including his position as a member of the Board of Managers, effective August 3, 2026. This is a clear executive departure disclosure under Item 5.02(b), and the resignation of a board member and officer of the managing owner is material to investors in the fund.
View raw filing on EDGAR →Mr. Jordan Krugman resigned from all positions at Invesco Specialized Products, LLC and its affiliates, including his position as a member of the Board of Managers of the Sponsor, effective August 3, 2026. This is a clear executive departure disclosure under Item 5.02, and the resignation of a board member from the Sponsor managing the Trust is material to investors in the fund.
View raw filing on EDGAR →Mr. Jordan Krugman resigned from all positions at Invesco Specialized Products, LLC and its affiliates, including his position as a member of the Board of Managers of the Sponsor, effective August 3, 2026. This is a clear executive departure disclosure under Item 5.02, and the resignation of a board member at the Sponsor managing the Trust is material to investors in the fund.
View raw filing on EDGAR →Mr. Jordan Krugman resigned from all positions at Invesco Specialized Products, LLC and its affiliates, including his position as a member of the Board of Managers of the Sponsor, effective August 3, 2026. This is a clear executive departure disclosure under Item 5.02, and the resignation of a board member at the Sponsor managing the Trust is material to investors in the fund.
View raw filing on EDGAR →Mr. Jordan Krugman's resignation from all positions at Invesco Capital Management LLC and its affiliates, including his role as a member of the Board of Managers of the Sponsor, effective August 3, 2026, constitutes a departure of a key officer. The disclosure explicitly states the resignation notice and effective date, which is the hallmark of an exec_departure event under Item 5.02(b).
View raw filing on EDGAR →Mr. Jordan Krugman resigned from all positions at Invesco Specialized Products, LLC (the Sponsor) and its affiliates, including his position as a member of the Board of Managers, effective August 3, 2026. This is a clear executive departure disclosure under Item 5.02, as the principal action is a named officer leaving his roles. The departure of a board member and officer at the Sponsor is material to investors in the Trust.
View raw filing on EDGAR →Mr. Jordan Krugman resigned from all positions at Invesco Specialized Products, LLC (the Sponsor) and its affiliates, including his position as a member of the Board of Managers, effective August 3, 2026. This is a clear executive departure disclosure under Item 5.02, as the principal action is a named officer leaving his roles. The departure of a board member and officer at the Sponsor is material to investors in the Trust.
View raw filing on EDGAR →Mr. Jordan Krugman resigned from all positions at Invesco Specialized Products, LLC (the Sponsor) and its affiliates, including his position as a member of the Board of Managers, effective August 3, 2026. This is a clear executive departure disclosure under Item 5.02, as the principal action is a named officer leaving his roles. The departure of a board member and officer at the Sponsor is material to investors in the Trust.
View raw filing on EDGAR →Mr. Jordan Krugman's resignation from all positions at Invesco Capital Management LLC and its affiliates, including his position as a member of the Board of Managers of the Sponsor, effective August 3, 2026, constitutes a departure of an officer/manager. The disclosure is material as it affects the governance and management structure of the fund's sponsor, which would be relevant to investors in the ETF.
View raw filing on EDGAR →Mr. Jordan Krugman resigned from all positions at Invesco Capital Management LLC, including his position as a member of the Board of Managers of the Managing Owner, effective August 3, 2026. This is a clear departure of an officer/manager from the registrant's managing owner, disclosed under Item 5.02(b), and would be material to investors in the fund.
View raw filing on EDGAR →Mr. Jordan Krugman resigned from all positions at Invesco Capital Management LLC, including his role as a member of the Board of Managers of the Managing Owner, effective August 3, 2026. This is a clear departure of an officer/manager from the registrant's managing owner, disclosed under Item 5.02(b), and would materially affect investor assessment of the fund's governance and management continuity.
View raw filing on EDGAR →Ms. Lisa Locklear, Chief Financial Officer of Longeveron Inc., informed management on June 1, 2026 of her decision to step down, effective July 10, 2026. While the filing also mentions the anticipated elevation of Marie Washburn to CFO, the principal disclosed action is the departure of a named executive officer (CFO). The resignation was not due to disagreement and is material to investors assessing management continuity.
View raw filing on EDGAR →Theresa Greco, Chief Commercial Officer, is departing OptimizeRx Corporation effective June 15, 2026, pursuant to a separation agreement executed June 1, 2026. While the filing also discloses severance and advisory arrangement terms, the principal disclosed action is the departure of a named executive officer from her role, making exec_departure the most salient classification. The departure of a CCO is material to investors' assessment of the company's commercial leadership and strategy.
View raw filing on EDGAR →Eric Haynor, the Chief Operating Officer, resigned effective June 5, 2026. The filing explicitly states his resignation and confirms it was not due to disagreement with the Company. This is a departure of a named executive officer and would materially affect investor assessment of the registrant's leadership and operational continuity.
View raw filing on EDGAR →Henry Liu resigned as Co-Chief Executive Officer effective June 2, 2026, with no disagreement cited. The filing discloses under Item 5.02 that following his departure, Yang Li now serves as sole CEO. This is a material executive departure affecting the company's leadership structure.
View raw filing on EDGAR →The filing discloses the resignation of two senior executives effective immediately: Christopher J. Porcelli (General Counsel, Chief People Officer, and Corporate Secretary) and Brian Brady (non-executive Chairman and Board member). These are material departures of named officers and a director that would affect investor assessment of the company's governance and leadership continuity. The immediate effective date and lack of transition details heighten materiality.
View raw filing on EDGAR →Alka Chaubey, Ph.D., Chief Medical Officer of Bionano Genomics, resigned effective July 5, 2026. This is a clear departure of a named executive officer disclosed under Item 5.02, and the departure of a CMO—a senior leadership position—is material to investors' assessment of the company's medical and scientific direction.
View raw filing on EDGAR →Wilfred Daye resigned as both a director and Chief Strategy Officer of Chaince Digital Holdings Inc., effective immediately on June 3, 2026. This is a clear executive departure under Item 5.02, involving the loss of a senior officer and board member. The filing explicitly states the resignation was voluntary and not due to disagreement, but the departure of a C-suite executive and director is material to investors assessing the company's leadership and governance.
View raw filing on EDGAR →The filing discloses the resignation of two directors (David E. Lazar and Avraham Ben-Tzvi, effective June 5, 2026) and the Chief Operating Officer (Walt A. Linscott, effective June 1, 2026). While Linscott transitions to a consulting role, the primary disclosed action is the departure of these executives from their positions. The filing explicitly states these resignations were not due to disagreement, but the simultaneous departure of multiple board members and a C-suite officer is material to investors assessing governance and leadership continuity.
View raw filing on EDGAR →DeEtte Gray, President of U.S. Operations, notified the Company on June 1, 2026 of her intention to retire effective June 30, 2026. While the disclosure also details a transition agreement with compensatory terms for a post-retirement advisory role through December 31, 2026, the principal disclosed action is the departure of a named executive officer from her operational role. The retirement of a President-level executive is material to investors assessing management continuity and operational leadership.
View raw filing on EDGAR →Jared Stanley resigned from his position as a member of the Board of Directors effective June 3, 2026, though he will continue in an advisory capacity. The departure was announced via press release on June 5, 2026 and does not relate to any disagreement with the company.
View raw filing on EDGAR →